Brookfield Corporation · BN · FY2026 Q2 · Calendar Q3 2026
Brookfield reports 15% DE growth as fundraising and AI infrastructure expand
Brookfield’s Q2 analysis supports a constructive operating thesis: earnings growth, fundraising and demand for AI, energy-transition and retirement infrastructure broaden the platform’s opportunity set. The counterweight is execution, financing and rate sensitivity, especially in AI infrastructure and insurance.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about BN FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current quarter showed stronger reported momentum, completion of the Just Group and Oaktree acquisitions, record fundraising and larger AI and nuclear infrastructure commitments. Wealth Solutions also showed continued annuity-sales momentum.
Guidance delta
Management maintained its guidance stance; no new quantitative guidance change was supplied.
Key takeaways
- Distributable earnings rose 15% year over year, with growth across business lines.
- Record $77 billion of fundraising lifted deployable capital to $210 billion.
- Management emphasized AI infrastructure, nuclear power, annuities and pension solutions as growth areas.
Management priorities
- Advance the Kentucky AI factory and compute-financing platform with NVIDIA.
- Expand U.S. annuity distribution through banks and broker-dealers.
- Scale Just Group’s U.K. pension risk-transfer franchise and pursue P&C insurance opportunities.
Follow BN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Aug 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 12, 2026 |
| TD Securities | Buy | Buy | Maintain | Nov 14, 2025 |
| CIBC | Outperform | Outperform | Maintain | Nov 14, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 15, 2024 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Aug 9, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 31, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $38.02. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Scotiabank | Mario Saric | $54 | $43.68 | +42.0% | Aug 14, 2026 |
| Morgan Stanley | Analyst unavailable | $59 | $42.41 | +55.2% | Jul 21, 2026 |
| TD Securities | Cherilyn Radbourne | $60 | $45.06 | +57.8% | May 19, 2026 |
| Scotiabank | Analyst unavailable | $53 | $45.76 | +39.4% | May 15, 2026 |
| RBC Capital | Analyst unavailable | $61 | $45.6 | +60.4% | May 15, 2026 |
| Morgan Stanley | Michael Cyprys | $61 | $47.44 | +60.4% | Apr 21, 2026 |
| Morgan Stanley | Michael Cyprys | $60 | $47.39 | +57.8% | Feb 17, 2026 |
| Scotiabank | Analyst unavailable | $52 | $47.91 | +36.8% | Feb 13, 2026 |
| Morgan Stanley | Analyst unavailable | $58 | $46.98 | +52.5% | Jan 27, 2026 |
| BMO Capital | Sohrab Movahedi | $49 | $44.99 | +28.9% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $58 | $45.66 | +52.5% | Dec 15, 2025 |
| CIBC | Analyst unavailable | $52 | $43.6 | +36.8% | Nov 14, 2025 |
| Morgan Stanley | Analyst unavailable | $54 | $44.2 | +42.0% | Oct 13, 2025 |
| Goldman Sachs | Alexander Blostein | $52 | $43.81 | +36.8% | Sep 2, 2025 |
| TD Securities | Analyst unavailable | $54.67 | $44.79 | +43.8% | Aug 5, 2025 |
| Scotiabank | Analyst unavailable | $50 | $44.98 | +31.5% | Jul 30, 2025 |
| BMO Capital | Sohrab Movahedi | $41.33 | $37.88 | +8.7% | Nov 15, 2024 |
| CIBC | Dean Wilkinson | $38 | $29.8 | -0.1% | Aug 9, 2024 |
| Scotiabank | Mario Saric | $34.17 | $29.63 | -10.1% | Aug 9, 2024 |
| RBC Capital | Geoffrey Kwan | $37.33 | $29.63 | -1.8% | Aug 9, 2024 |
| BMO Capital | Sohrab Movahedi | $30.67 | $29.34 | -19.4% | May 10, 2024 |
| Credit Suisse | Analyst unavailable | $27.33 | $25.13 | -28.1% | Feb 6, 2023 |
| TD Securities | Cherilyn Radbourne | $48 | $33.25 | +26.2% | Sep 9, 2022 |
| Deutsche Bank | Brian Bedell | $38 | $31.39 | -0.1% | May 21, 2022 |
| Deutsche Bank | Brian Bedell | $40 | $30.29 | +5.2% | May 13, 2022 |
| Credit Suisse | Analyst unavailable | $47.67 | $33.16 | +25.4% | Apr 27, 2022 |
| Scotiabank | Mario Saric | $42 | $37.51 | +10.5% | Aug 16, 2021 |
Track every rating change on BN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBrookfield Corporation operates as a leading alternative asset and real estate investment management firm. It specializes in real estate, renewable power, infrastructure, venture capital, and private equity, providing a diverse range of public and private investment products and services to institutional and individual clients alike. The firm's investment approach centers on acquiring substantial, high-quality assets worldwide, utilizing both its proprietary capital and funds contributed by other investors. Within its private equity and venture capital divisions, Brookfield engages in a broad spectrum of activities, including growth equity, early-stage investments, control and distressed buyouts, corporate spin-offs, recapitalizations, and various forms of debt financing (convertible, senior, and mezzanine). It also focuses on operational and capital structure restructuring, strategic turnarounds, and revitalizing underperforming mid-market companies.…
Financial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the BN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-13T16:16:28.071740+00:00
- FN2 earnings calendar · 2026-09-18T01:23:15.369793+00:00
- Polygon adjusted daily market bars · 2026-09-21T15:50:49.260872+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T15:50:49.257837+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.